Clinical trial
Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients…
NCT00381875 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00381875 |
|---|---|
| Title | Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV |
| Official title | A Pilot Study to Investigate the Safety and Immunogenicity of a Peptide Vaccine for HIV Infected HLA-A2 Individuals Designed to Impede the Development of Antiretroviral Resistance |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nonneoplastic Condition |
| Intervention type | Biological, Other |
| Interventions | E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim, immunoenzyme technique |
| Enrollment | 40 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Sep 28, 2006 |
| Last update posted | May 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: